Literature DB >> 21947260

Rhesus monkey TRIM5α has distinct HIV-1 restriction activity among different mammalian cell lines.

Jian Gong1, Xi-Hui Shen, Hui Qiu, Chao Chen, Rong-Ge Yang.   

Abstract

Rhesus monkey TRIM5α (TRIM5α(rh)), a member of the tripartite motif (TRIM) family, was identified as the main restriction factor responsible for resistance of old world monkey cells to HIV-1 infection. However, the precise mechanism of HIV-1 infection inhibition by TRIM5α remains elusive and appears to be related to some cellular cofactors. Here we reported that TRIM5α(rh) can significantly reduce the infection efficiency of VSV-G pseudotyped HIV-1/MA-YFP virus in human epithelial carcinoma (HeLa) cells, moderately reduce in porcine kidney (PK-15) cells and have no effect on the pseudotyped virus infection in Madin-Darby canine kidney (MDCK) cells. Furthermore, we found that the different HIV-1 restriction activities have no relation with the intracellular localization of TRIM5α(rh). These results indicate that the cellular environment is very important for the efficient anti-HIV-1 activity of TRIM5α(rh). We speculate that some unknown factors required for HIV-1 infection inhibition activity are adequately expressed in HeLa cells, inadequately expressed in PK-15 cells and absent in MDCK cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947260     DOI: 10.1007/s00284-011-0009-z

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  18 in total

1.  Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.

Authors:  Jenny L Anderson; Edward M Campbell; Xiaolu Wu; Nick Vandegraaff; Alan Engelman; Thomas J Hope
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.

Authors:  Matthew Stremlau; Michel Perron; Mark Lee; Yuan Li; Byeongwoon Song; Hassan Javanbakht; Felipe Diaz-Griffero; Donovan J Anderson; Wesley I Sundquist; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-15       Impact factor: 11.205

3.  Molecular characterization of the B-box protein-protein interaction motif of the ETS-domain transcription factor Elk-1.

Authors:  Y Ling; J H Lakey; C E Roberts; A D Sharrocks
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

4.  Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins.

Authors:  Ryuta Sakuma; Josh A Noser; Seiga Ohmine; Yasuhiro Ikeda
Journal:  Nat Med       Date:  2007-04-15       Impact factor: 53.440

5.  TRIM11 binds to and destabilizes a key component of the activator-mediated cofactor complex (ARC105) through the ubiquitin-proteasome system.

Authors:  Hideaki Ishikawa; Hiroyuki Tachikawa; Yutaka Miura; Nobuhiro Takahashi
Journal:  FEBS Lett       Date:  2006-08-04       Impact factor: 4.124

6.  The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.

Authors:  Hassan Javanbakht; Felipe Diaz-Griffero; Matthew Stremlau; Zhihai Si; Joseph Sodroski
Journal:  J Biol Chem       Date:  2005-05-15       Impact factor: 5.157

7.  All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.

Authors:  Sadayuki Ohkura; Melvyn W Yap; Tom Sheldon; Jonathan P Stoye
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Tetherin inhibits HIV-1 release by directly tethering virions to cells.

Authors:  David Perez-Caballero; Trinity Zang; Alaleh Ebrahimi; Matthew W McNatt; Devon A Gregory; Marc C Johnson; Paul D Bieniasz
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

Review 9.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

10.  Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells.

Authors:  Julie Bérubé; Amélie Bouchard; Lionel Berthoux
Journal:  Retrovirology       Date:  2007-09-24       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.